NOVATO, Calif., June 19, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer at BioMarin, will present a company update at the NASDAQ OMX 28th Investor Program in London on Tuesday, June 26, 2012 at 1:45 p.m. BST.
